Related Experiment Videos
Replacement therapy in patients with hereditary antithrombin III deficiency
1Blood Services, American Red Cross, National Headquarters, Washington, DC 20006.
Seminars in Hematology
|January 1, 1991
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Pharmacokinetics of von Willebrand factor and factor VIII coagulant activity in patients with von Willebrand disease type 3 and type 2.
Haemophilia : the official journal of the World Federation of Hemophilia·1999
New treatments of von Willebrand disease: plasma derived von Willebrand factor concentrates.
Thrombosis and haemostasis·1997
Creutzfeldt-Jakob disease: current U.S. policy to further reduce the possible risk of transmission by transfusion.
Biologicals : journal of the International Association of Biological Standardization·1996
Safety monitoring and epidemiological surveillance of blood transfusion in the United States.
Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·1995
Antithrombin III concentrates.
Hematology/oncology clinics of North America·1992
Germline predisposition in myeloproliferative neoplasms.
Seminars in hematology·2026
Alloimmunization in sickle cell disease: Addressing an ongoing clinical challenge.
Seminars in hematology·2026
Pain in SCD-Many mechanisms and mysteries.
Seminars in hematology·2026
The many facets of cardiopulmonary complications in sickle cell disease.
Seminars in hematology·2026